1-[4-[(4-氯苯基)甲基]苯基]-3-(4-苯基-3,6-二氢-2H-吡啶-1-基)丙烷-1-醇 | 143462-72-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-[4-[(4-氯苯基)甲基]苯基]-3-(4-苯基-3,6-二氢-2H-吡啶-1-基)丙烷-1-醇
• 英文名称: (+/-)-1-<4-(4-chlorobenzyl)-phenyl>-3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-1-propanol
• 英文别名: 3-(4-Phenyl-1,2,3,6-tetrahydro-1-pyridyl)-1-[4-(4-chloro-benzyl)-phenyl]-1-propanol；3,6-Dihydro-alpha-(4-((4-chlorophenyl)methyl)phenyl)-4-phenyl-1(2H)-pyridinepropanol；1-[4-[(4-chlorophenyl)methyl]phenyl]-3-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)propan-1-ol
• CAS: 143462-72-0；180959-21-1；180959-23-3
• 化学式: C₂₇H₂₈ClNO
• 分子量: 417.978
• InChiKey: JENXCJFCDKATHK-UHFFFAOYSA-N

物化性质

• 沸点：
  587.7±50.0 °C(Predicted)
• 密度：
  1.169±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.9
• 重原子数：
  30
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-[4-[(4-氯苯基)甲基]苯基]-3-(4-苯基-3,6-二氢-2H-吡啶-1-基)丙烷-1-醇 生成 (+)-1-[4-(4-chlorobenzyl)-phenyl]-3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-1-propanol
  参考文献：
  名称：

  Resolution of racemic 1,3-disubstituted propanols by (R,R)-di-(4-toluoyl)-tartaric acid: Similar conditions for similar structures

  摘要：

  The resolution of structurally similar (+/-)-1-[4-(4- chlorobenzyl)-phenyl]-3-(4-phenyl-1,2,3,6-tetrahydropyridin- 1-yl)-1-propanol and (+/-)-1-(1,1'-biphenyl-4-yl)-3-[4-(4-fluorophenyl)-piperazin- 1-yl]-1-propanol was accomplished by (R,R)-di-(4-toluoyl)-tartaric acid in methanol. The experiments illustrate the possibilities for selecting the resolving agent for a racemate which is available in insufficient quantity by making the trial experiments on a structurally similar racemates. (C) 1996 Elsevier Science Ltd

  DOI：

  10.1016/0957-4166(96)00188-7
• 作为产物：
  描述：

  4-氯二苯基甲烷 在 盐酸 、 sodium hydroxide 、 sodium tetrahydroborate 、 三氯化铝 作用下， 以 甲醇 、 乙醇 、 硝基苯 为溶剂， 反应 30.0h， 生成 1-[4-[(4-氯苯基)甲基]苯基]-3-(4-苯基-3,6-二氢-2H-吡啶-1-基)丙烷-1-醇
  参考文献：
  名称：

  Novel 1,2,3,6-tetrahydropyridine derivatives with potent antihypoxic activity

  摘要：

  A number of 1,2,3,6-tetrahydropyridine derivatives 1a-u were synthesised. They were examined for their antihypoxic actions in mice and rats using various hypoxic tests (eg, hypobaric hypoxia, cytotoxic hypoxia, and asphyxic anoxia). Some of the compounds described displayed significant antihypoxic activity. The antihypoxic activity of the most effective compound (1q) is propably unrelated to the hypothermising action. The participation of adrenergic and serotoninergic receptors in this effect can also be excluded. However, the activity of this compound may be related to the inhibition of cellular Ca2+ movement.

  DOI：

  10.1016/0223-5234(94)90059-0

文献信息

• 1,2,3,6-Tetrahydropyridine derivatives
  申请人：RICHTER GEDEON VEGYESZETI GYAR R.T.

  公开号：EP0490560B1

  公开（公告）日：1996-03-20
• US5225416A
  申请人：——

  公开号：US5225416A

  公开（公告）日：1993-07-06
• Novel 1,2,3,6-tetrahydropyridine derivatives with potent antihypoxic activity
  作者：T Gizur、B Kiss、K Harsányi、E Kárpáti、É Pálosi、A Gere、E Lapis、I Laszlovszky、S Szabó、L Szporny

  DOI：10.1016/0223-5234(94)90059-0

  日期：1994.1

  A number of 1,2,3,6-tetrahydropyridine derivatives 1a-u were synthesised. They were examined for their antihypoxic actions in mice and rats using various hypoxic tests (eg, hypobaric hypoxia, cytotoxic hypoxia, and asphyxic anoxia). Some of the compounds described displayed significant antihypoxic activity. The antihypoxic activity of the most effective compound (1q) is propably unrelated to the hypothermising action. The participation of adrenergic and serotoninergic receptors in this effect can also be excluded. However, the activity of this compound may be related to the inhibition of cellular Ca2+ movement.
• Resolution of racemic 1,3-disubstituted propanols by (R,R)-di-(4-toluoyl)-tartaric acid: Similar conditions for similar structures
  作者：Tibor Gizur、Imre Péteri、Kálmán Harsányi、Elemér Fogassy

  DOI：10.1016/0957-4166(96)00188-7

  日期：1996.6

  The resolution of structurally similar (+/-)-1-[4-(4- chlorobenzyl)-phenyl]-3-(4-phenyl-1,2,3,6-tetrahydropyridin- 1-yl)-1-propanol and (+/-)-1-(1,1'-biphenyl-4-yl)-3-[4-(4-fluorophenyl)-piperazin- 1-yl]-1-propanol was accomplished by (R,R)-di-(4-toluoyl)-tartaric acid in methanol. The experiments illustrate the possibilities for selecting the resolving agent for a racemate which is available in insufficient quantity by making the trial experiments on a structurally similar racemates. (C) 1996 Elsevier Science Ltd